HF
VYGR icon

HRT Financial’s Voyager Therapeutics VYGR Stock Holding History

HRT Financial’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,508
Closed -$60K – 4823
2025
Q4 		$60K Sell
15,508
-21,837
-58% -$96.6K ﹤0.01% 2855
2025
Q3 		$174K Buy
+37,345
New +$135K ﹤0.01% 2436
2023
Q2 		– Sell
-90,885
Closed -$700K – 3366
2023
Q1 		$700K Buy
+90,885
New +$723K 0.01% 1161
2022
Q2 		– Sell
-12,782
Closed -$97K – 3813
2022
Q1 		$97K Buy
+12,782
New +$57K ﹤0.01% 2666
2021
Q4 		– Sell
-52,038
Closed -$136K – 4175
2021
Q3 		$136K Sell
52,038
-20,087
-28% -$65.2K ﹤0.01% 2814
2021
Q2 		$297K Buy
+72,125
New +$327K ﹤0.01% 2146
2021
Q1 		– Sell
-21,258
Closed -$151K – 3202
2020
Q4 		$151K Buy
+21,258
New +$204K ﹤0.01% 1571

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HRT Financial's VYGR Position: Q1 2026 in Review

HRT Financial sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 15,508 shares — an estimated $60K sold.

HRT Financial first reported a position in VYGR in Q4 2020 and held it in 7 quarters. The position peaked at $700K in Q1 2023. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • HRT Financial reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 15,508 Voyager Therapeutics shares in Q1 2026, an estimated $60K.
  • HRT Financial first reported a position in Voyager Therapeutics in Q4 2020 and held it in 7 quarters.
  • HRT Financial's Voyager Therapeutics position peaked at $700K in Q1 2023.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.